paclitaxel has been researched along with Acute Promyelocytic Leukemia in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Bittencourt, R; Coelho-Silva, JL; Costa-Lotufo, LV; de Figueiredo-Pontes, LL; de Melo, RA; Fagundes, EM; Kerbauy, F; Koury, LC; Lima, K; Lipreri da Silva, JC; Lucena-Araujo, AR; Machado-Neto, JA; Nunes, E; Pagnano, K; Pereira-Martins, DA; Rego, EM; Scheucher, PS; Traina, F; Vicari, HP | 1 |
Feng, N; Guo, T; Hou, X; Li, Z; Liu, W; Xia, Q; Zhang, Y; Zhu, C | 1 |
Asik, A; Balcı Okcanoglu, T; Biray Avci, C; Dogan Sigva, ZO; Gunduz, C; Kayabasi, C; Ozmen Yelken, B; Saydam, G; Yılmaz Susluer, S | 1 |
Beil, M; Bruel, A; Guck, J; Lautenschläger, F; Paschke, S; Schinkinger, S | 1 |
da Silva, J; Guck, JR; Lautenschläger, F; Sivaniah, E | 1 |
Chan, A; Miller, JH; Rawson, P; William Jordan, T; Wilmes, A | 1 |
Damon, L; Demirer, T; Derigs, G; Ferrante, P; Kröger, N; Rosti, G; Wandt, H; Zander, AR | 1 |
Bhalla, K; Huang, Y; Kumar, G; Ray, S; Self, S; Walle, T; Willingham, M | 1 |
Davey, MW; Davey, RA; Mote, PA; Oliver, L | 1 |
Cohen, MH; Flamm Honig, S; Hirschfeld, S; Ibrahim, A; Johnson, JR; O'Leary, JJ; Pazdur, R; White, RM; Williams, GA | 1 |
Allison, DC; Donehower, RC; Roberts, JR; Robertson, J; Rowinsky, EK | 1 |
1 review(s) available for paclitaxel and Acute Promyelocytic Leukemia
Article | Year |
---|---|
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Incidence; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Lymphatic Metastasis; Melphalan; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Thiotepa; Transplantation Conditioning; Transplantation, Autologous | 2003 |
10 other study(ies) available for paclitaxel and Acute Promyelocytic Leukemia
Article | Year |
---|---|
STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells.
Topics: Cell Differentiation; Cell Proliferation; Humans; Leukemia, Promyelocytic, Acute; Mitosis; Oncogene Proteins, Fusion; Paclitaxel; Stathmin | 2022 |
Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
Topics: Abietanes; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Folic Acid; Humans; Leukemia, Promyelocytic, Acute; Lipid Bilayers; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Silicon Dioxide; Xenograft Model Antitumor Assays | 2020 |
Antileukemic effect of paclitaxel in combination with metformin in HL-60 cell line.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Drug Therapy, Combination; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Metformin; NF-kappa B; Oxides; Paclitaxel; Signal Transduction | 2018 |
The regulatory role of cell mechanics for migration of differentiating myeloid cells.
Topics: Actin Cytoskeleton; Biomechanical Phenomena; Biophysical Phenomena; Cell Differentiation; Cell Line, Tumor; Cell Movement; Compliance; Humans; Leukemia, Promyelocytic, Acute; Microfluidic Analytical Techniques; Microtubules; Myeloid Cells; Paclitaxel; Tretinoin; Tubulin Modulators | 2009 |
The cavity-to-cavity migration of leukaemic cells through 3D honey-combed hydrogels with adjustable internal dimension and stiffness.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Cell Movement; Elasticity; Humans; Hydrogels; Leukemia, Promyelocytic, Acute; Materials Testing; Paclitaxel; Porosity; Tissue Scaffolds; Tretinoin; Tumor Cells, Cultured | 2010 |
Paclitaxel effects on the proteome of HL-60 promyelocytic leukemic cells: comparison to peloruside A.
Topics: Antineoplastic Agents; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Down-Regulation; G2 Phase Cell Cycle Checkpoints; HL-60 Cells; Humans; Lactones; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Paclitaxel; Proteomics; Proto-Oncogene Proteins c-myc; Two-Dimensional Difference Gel Electrophoresis | 2012 |
Comparative in vitro cytotoxic effects of taxol and its major human metabolite 6 alpha-hydroxytaxol.
Topics: Apoptosis; Cell Division; Cell Line; Cell Survival; Cell-Free System; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Microtubules; Mitosis; Nucleosomes; Paclitaxel; Taxoids; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1995 |
Paclitaxel sensitizes multidrug resistant cells to radiation.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Death; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Leukemia, Promyelocytic, Acute; Paclitaxel; Radiation-Sensitizing Agents; Time Factors; Tumor Cells, Cultured; Verapamil | 1996 |
Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene.
Topics: Anastrozole; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Arsenic Trioxide; Arsenicals; Bexarotene; Breast Neoplasms; Drug Approval; Female; Humans; Leukemia, Promyelocytic, Acute; Lymphoma, T-Cell, Cutaneous; Nitriles; Oxides; Paclitaxel; Tamoxifen; Tetrahydronaphthalenes; Triazoles; United States; United States Food and Drug Administration | 2001 |
Demonstration of the cell cycle positions of taxol-induced "asters" and "bundles" by sequential measurements of tubulin immunofluorescence, DNA content, and autoradiographic labeling of taxol-sensitive and -resistant cells.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Autoradiography; Cell Cycle; Cell Line; DNA; Drug Resistance; Fluorescent Antibody Technique; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Microscopy, Electron; Microtubules; Mitosis; Paclitaxel; Thymidine; Tubulin | 1989 |